These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 8425199

  • 21. Interferon (IFN)-gamma , tumor necrosis factor-alpha , interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis.
    Ansari NA, Ramesh V, Salotra P.
    J Infect Dis; 2006 Oct 01; 194(7):958-65. PubMed ID: 16960784
    [Abstract] [Full Text] [Related]

  • 22. IL-4 and IFN-gamma increase steady state levels of polymeric Ig receptor mRNA in human airway and intestinal epithelial cells.
    Ackermann LW, Wollenweber LA, Denning GM.
    J Immunol; 1999 May 01; 162(9):5112-8. PubMed ID: 10227981
    [Abstract] [Full Text] [Related]

  • 23. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses.
    Scheurich P, Thoma B, Ucer U, Pfizenmaier K.
    J Immunol; 1987 Mar 15; 138(6):1786-90. PubMed ID: 3029221
    [Abstract] [Full Text] [Related]

  • 24. Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses.
    Elner VM, Burnstine MA, Strieter RM, Kunkel SL, Elner SG.
    Exp Eye Res; 1997 Dec 15; 65(6):781-9. PubMed ID: 9441701
    [Abstract] [Full Text] [Related]

  • 25. Reduced expression of c-erbB2 gene product in human mammary carcinoma SK-BR-3 cells treated with interferon-gamma and tumor necrosis factor-alpha.
    Kumar R, Mendelsohn J.
    Anticancer Res; 1994 Dec 15; 14(3A):1001-8. PubMed ID: 7915505
    [Abstract] [Full Text] [Related]

  • 26. Identification of constitutive and gamma-interferon- and interleukin 4-regulated proteins in the human renal carcinoma cell line ACHN.
    Sullivan CM, Smith DM, Matsui NM, Andrews LE, Clauser KR, Chapeaurouge A, Burlingame AL, Epstein LB.
    Cancer Res; 1997 Mar 15; 57(6):1137-43. PubMed ID: 9067284
    [Abstract] [Full Text] [Related]

  • 27. Regulation of interleukin 8 expression in human malignant melanoma cells.
    Singh RK, Varney ML.
    Cancer Res; 1998 Apr 01; 58(7):1532-7. PubMed ID: 9537260
    [Abstract] [Full Text] [Related]

  • 28. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
    Mori K, Stone S, Khaodhiar L, Braverman LE, DeVito WJ.
    J Cell Biochem; 1999 Aug 01; 74(2):211-9. PubMed ID: 10404391
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cytokine modulation of human corneal epithelial cell ICAM-1 (CD54) expression.
    Yannariello-brown J, Hallberg CK, Häberle H, Brysk MM, Jiang Z, Patel JA, Ernst PB, Trocme SD.
    Exp Eye Res; 1998 Oct 01; 67(4):383-93. PubMed ID: 9820785
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells.
    Fisher PB, Hermo H, Solowey WE, Dietrich MC, Edwalds GM, Weinstein IB, Langer JA, Pestka S, Giacomini P, Kusama M.
    Anticancer Res; 1986 Oct 01; 6(4):765-74. PubMed ID: 2944474
    [Abstract] [Full Text] [Related]

  • 35. Tumor necrosis factor alpha and interferon gamma--induced cell growth arrest is mediated via insulin-like growth factor binding protein-3.
    Katz J, Nasatzky E, Werner H, Le Roith D, Shemer J.
    Growth Horm IGF Res; 1999 Jun 01; 9(3):174-8. PubMed ID: 10502453
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma.
    Penton-Rol G, Polentarutti N, Luini W, Borsatti A, Mancinelli R, Sica A, Sozzani S, Mantovani A.
    J Immunol; 1998 Apr 15; 160(8):3869-73. PubMed ID: 9558092
    [Abstract] [Full Text] [Related]

  • 38. Human interleukin 2 analogues that preferentially bind the intermediate-affinity interleukin 2 receptor lead to reduced secondary cytokine secretion: implications for the use of these interleukin 2 analogues in cancer immunotherapy.
    Heaton KM, Ju G, Grimm EA.
    Cancer Res; 1993 Jun 01; 53(11):2597-602. PubMed ID: 8495422
    [Abstract] [Full Text] [Related]

  • 39. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.
    Albanesi C, Cavani A, Girolomoni G.
    J Immunol; 1999 Jan 01; 162(1):494-502. PubMed ID: 9886425
    [Abstract] [Full Text] [Related]

  • 40. Modulation of cell proliferation by human recombinant interleukin-1 and immune interferon.
    Tsai SC, Gaffney EV.
    J Natl Cancer Inst; 1987 Jul 01; 79(1):77-81. PubMed ID: 3110477
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.